title: Is there still a place for itraconazole prophylaxis in high-risk hematology patients?
authors.affiliation: Department of Microbiology and Infectious Diseases, Royal Prince Alfred Hospital, Sydney, Australia, Sebastian.vanhal@sswahs.nsw.gov.au.
authors.forename: S J
authors.initials: SJ
authors.lastname: van Hal
authors.forename: S R
authors.initials: SR
authors.lastname: Larsen
authors.forename: R C
authors.initials: RC
authors.lastname: Chan
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D009181:Mycoses / Q000517:prevention & control*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D000935:Antifungal Agents; D014230:Triazoles